ISSN: 1230-2813
Advances in Psychiatry and Neurology/Postępy Psychiatrii i Neurologii
Current issue Archive Manuscripts accepted About the journal Scientific board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank
4/2020
vol. 29
 
Share:
Share:
more
 
 
abstract:
Case report

Orthostatic syncopein in a young woman with essential thrombocythemia found to be an initial sign of ischemic stroke – therapeutic concerns. Unusual case

Małgorzata Wiszniewska
1, 2
,
Andrzelika Domagalska
2
,
Paweł Wiszniewski
3

1.
Stanisław Staszic University of Applied Sciences, Faculty of Nursing, Piła, Poland
2.
Specialist Hospital, Neurological Department with Stroke Unit, Piła, Poland
3.
Hematological Department, Ars Medical Hospital, Piła, Poland
Adv Psychiatry Neurol 2020; 29 (4): 246-249
Online publish date: 2021/01/30
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Purpose
Essential thrombocythemia (ET) is characterised by an overproduction of platelets in the absence of the states that induce secondary thrombopoiesis. The most common and significant complication of ET is arterial and venous thrombosis. The most serious complication of ET is stroke.

Case description
We present a patient with a stroke that started with an unusual symptom – syncope, successfully treated with recombinant tissue plasminogen activator alteplase. Three years after the stroke, the patient lives an independent life but with cerebellar-stem symptoms. Further long-term treatment is supervised by a haematologist.

Comment
Syncope in ET may be the first sign of stroke. To assess brainstem and cerebellar stroke, magnetic resonance imaging should be performed. In ET, thrombolytic treatment of ischemic stroke may be a life-saving treatment. Long-term treatment involving a platelet-lowering medication, along with anti-aggregation drugs, is necessary to treat stroke patients with ET. Females with ET who have suffered from a stroke should not use oral contraception.

keywords:

ischemic stroke, essential thrombocythemia, JAK2 V617F mutation, platelets, risk factors

Quick links
© 2021 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe